Table 3 Demographic characteristics
From: Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
| Â | Cornea and ocular surface | Uveitis | Retina | Neuro-ophthalmic disorders | Orbit and ocular adnexa |
|---|---|---|---|---|---|
Mean age | 58.7 | 59.8 | 60.8 | 65.8 | 64.6 |
M/F ratio | 17/13 | 70/62 | 13/12 | 47/23 | 21/11 |
Race (if reported) | |||||
- Caucasian | 4 | 39 | 5 | 9 | 5 |
- Asian | Â | 10 | 2 | 1 | Â |
- Afro-American | 7 | Â | 1 | Â | |